Due to the latest success with CYP inhibitors as anti-cancer therapy, such as aromatase (CYP19) inhibitors [27], the potential to develop novel therapies may be offered by selective CYP4Z1 expression in certain cancers. The gene discussed is CYP19A1; the disease is cancer.